a comparative study of tacrolimus versus cyclosporine as immunosuppression for kidney transplant recipients
نویسندگان
چکیده
kidney transplantation is the most common transplantation in the world. annually, a large number of patients that have chronic renal failure are undergoing renal transplantation and the major subject about these patients is the rejection of graft that should be controlled by immunosuppressive agents. the aim of this study is investigation of the effect of cyclosporin against tacrolimus in patients with kidney transplantation. this study was performing between 2010 and 2012 on all patients who had kidney transplantation and refer to imam reza hospital from kermanshah university of medical sciences. 100 patients, aged 18–60 years, with end-stage renal disease were administered either tacrolimus (n=49) or cyclosporine (n=51). in both groups, cellept could be discontinued from day 92 onwards. corticosteroid treatment comprised methylprednisolone boluses followed by a rapid prednisone taper from 20 mg (day 2) to 5 mg (day 43 and thereafter). patients followed up 12 months. in the tacrolimus treatment group, 7 grafts (14%) were lost and 8 (16%) grafts were lost in the cyclosporine treatment group between months 0 and 12 and there is no significant different between these groups ( p= 0.845 ). no cases were diagnosed with biopsy-proven chronic rejection at months 0 and 12. mean serum creatinine concentrations were 1.8 ± 1.5 mg/dl in the tacrolimus group and 2.3 ±2.9 in the cyclosporine group by month 12 ( p= 0.348 ). these data are consistent with previously published observations and confirm that tacrolim us is a highly efficacious baseline immunosuppressant for patients undergoing kidney transplantation. tacrolimus-based immunosuppression may promote long-term benefits with regard to graft functio n and graft survival.
منابع مشابه
Dyslipidaemia among renal transplant recipients: cyclosporine versus tacrolimus.
OBJECTIVES To compare new onset dyslipidaemia in live-related renal transplant recipients taking cyclosporine versus tacrolimus after 3 months of therapy. METHODS The randomised controlled trial was conducted at the Sindh Institute of Urology and Transplantation (SIUT) Karachi, from September 2010 to April 2011, and included 182 End Stage Renal Disease patients on maintenance haemodialysis wi...
متن کاملA Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients
Pharmacokinetic analyses comparing generic tacrolimus preparations versus the reference drug in kidney transplant patients are lacking. A prospective, multicenter, open-label, randomized, two-period (14 days per period), two-sequence, crossover and steady-state pharmacokinetic study was undertaken to compare twice-daily generic tacrolimus (Sandoz) versus reference tacrolimus (Prograf®) in stabl...
متن کاملTacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.
OBJECTIVE To compare the positive and negative effects of tacrolimus and ciclosporin as initial treatment for renal transplant recipients. DESIGN Systematic review. DATA SOURCES AND STUDY SELECTION Reports of comparative randomised trials of tacrolimus and ciclosporin identified by searches of Medline, Embase, the Cochrane Register of Controlled Trials, the Cochrane Renal Group Specialist R...
متن کاملTacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis.
BACKGROUND Tacrolimus and cyclosporine microemulsion are the 2 major immunosuppressants for heart transplantation. Several studies have compared these 2 drugs, but the outcomes were not consistent. This meta-analysis of randomized controlled trials compared the beneficial and harmful effects of tacrolimus and microemulsion cyclosporine for heart transplant recipients. METHODS Electronic datab...
متن کاملClinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
Tacrolimus, a cornerstone of immunosuppressive therapy in solid organ transplantation, has a narrow therapeutic range with considerable inter-individual and intra-individual pharmacokinetic variability. To date, there is no information on the pharmacokinetics of tacrolimus in Iranian liver transplant recipients. This study was designed to determine pharmacokinetic properties of orally administe...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
journal of paramedical sciencesجلد ۴، شماره ۰۲، صفحات ۰-۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023